| Product Code: ETC9958282 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) mRNA Vaccine Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) mRNA Vaccine Market - Industry Life Cycle |
3.4 United Kingdom (UK) mRNA Vaccine Market - Porter's Five Forces |
3.5 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 United Kingdom (UK) mRNA Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of mRNA vaccines in the UK |
4.2.2 Government initiatives and funding to support mRNA vaccine research and development |
4.2.3 Rising prevalence of infectious diseases and pandemics driving the demand for vaccines |
4.3 Market Restraints |
4.3.1 Regulatory hurdles and approval process for mRNA vaccines in the UK |
4.3.2 Vaccine hesitancy and misinformation impacting vaccine uptake |
4.3.3 Supply chain challenges and logistics in distributing mRNA vaccines |
5 United Kingdom (UK) mRNA Vaccine Market Trends |
6 United Kingdom (UK) mRNA Vaccine Market, By Types |
6.1 United Kingdom (UK) mRNA Vaccine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By COVID-19, 2021- 2031F |
6.1.4 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) mRNA Vaccine Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By Government, 2021- 2031F |
6.2.3 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By Private Hospitals & Clinics, 2021- 2031F |
6.2.4 United Kingdom (UK) mRNA Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) mRNA Vaccine Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) mRNA Vaccine Market Export to Major Countries |
7.2 United Kingdom (UK) mRNA Vaccine Market Imports from Major Countries |
8 United Kingdom (UK) mRNA Vaccine Market Key Performance Indicators |
8.1 Vaccine acceptance rate among the UK population |
8.2 Number of mRNA vaccine clinical trials conducted in the UK |
8.3 Investment in mRNA vaccine research and development in the UK |
9 United Kingdom (UK) mRNA Vaccine Market - Opportunity Assessment |
9.1 United Kingdom (UK) mRNA Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) mRNA Vaccine Market Opportunity Assessment, By End users, 2021 & 2031F |
10 United Kingdom (UK) mRNA Vaccine Market - Competitive Landscape |
10.1 United Kingdom (UK) mRNA Vaccine Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) mRNA Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here